QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study - Concepedia

Concepedia

Publication | Closed Access

QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study

49

Citations

27

References

2020

Year

Olivier Bornert, Marieke Hogervorst, Pauline Nauroy, Johannes Bischof, Jim Swildens, Ioannis Athanasiou, Sara F. Tufa, Douglas R. Keene, Dimitra Kiritsi, Stefan Hainzl,

Journal of Investigative Dermatology

References

	Year	Citations

Page 1